Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. EJP RD –. European Joint Programme on Rare Diseases [Internet]. https://www.ejprarediseases.org.
2. Hilgers R-D, Roes K, Stallard N. Directions for new developments on statistical design and analysis of small population group trials. Orphanet J Rare Dis. 2016;11(1).
3. CHMP. Guideline on clinical trials in small populations. [Online] 2007. [Cited: February 1, 2013].www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003615.pdf.
4. Hilgers RD, Bogdan M, Burman CF, Dette H, Karlsson M, König F et al. Lessons learned from IDeAl — 33 recommendations from the IDeAl-net about design and analysis of small population clinical trials. Orphanet J Rare Dis. 2018;13(1).
5. Mitroiu M, Oude Rengerink K, Pontes C, Sancho A, Vives R, Pesiou S et al. Applicability and added value of novel methods to improve drug development in rare diseases. Orphanet J Rare Dis. 2018;13(1).